Faron Pharmaceuticals Oy
FARN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £219 | £234 | £188 | £162 |
| - Cash | £10 | £7 | £7 | £7 |
| + Debt | £12 | £13 | £13 | £4 |
| Enterprise Value | £222 | £240 | £194 | £159 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | -£0 | -£28 | -£27 | -£21 |
| % Margin | – | – | – | – |
| Net Income | -£0 | -£31 | -£29 | -£21 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.34 | -0.38 | -0.29 |
| % Growth | 99.9% | 10.5% | -31% | – |
| Operating Cash Flow | -£23 | -£24 | -£23 | -£22 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£23 | -£24 | -£23 | -£23 |